Open Access Journals



An Additional, Complementary Mechanism of Action for Folic Acid in the Treatment of Megaloblastic Anemia

Administration of supplemental folic acid addresses the impaired DNA synthesis causing megaloblastic anemia; however, despite the possibility of high doses of folic acid-5 to 15 milligrams (mg) daily for up to four months-the extremely rapid initial onset of action-30 to 60 minutes-when administered orally is not in keeping with the accepted mechanism, which can take up to nearly 22 hours, even under enzymatic control. This would suggest an additional, complementary non-enzymatic mechanism of nucleotide methylation at work; it is, therefore, proposed here, with in vitro evidence put forth, that rapid, non-enzymatic methylation by folic acid, via 5,10-methylenetetrahydrofolate and 7,8-tetrahydrofolate intermediates, of deoxyuridine monophosphate to form thymidylate using the cell membrane phospholipid phosphatidylcholine as a methyl donor, leaving de-methylated phosphatidylethanolamine, is a viable additional and complementary mechanism in helping reduce megaloblastic red blood cells to normal size and function.


Bruce K. Kowiatek

Abstract PDF Full Text

Submit Article to Us


Fortune Journals follows COPE Guidelines


Fortune Journals submit each review to Publons